DBV Technologies SA
F:DBV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
DBV Technologies SA
F:DBV
|
FR |
|
V
|
VCI Global Ltd
NASDAQ:VCIG
|
MY |
|
A
|
Alpha Pro Tech Ltd
F:APL
|
CA |
|
C
|
Celcuity Inc
NASDAQ:CELC
|
US |
|
P
|
Phoenix Group Holdings PLC
F:1BF
|
UK |
|
Discovex Resources Ltd
ASX:DCX
|
AU |
|
Mitra Pinasthika Mustika Tbk PT
IDX:MPMX
|
ID |
|
S
|
SAPPE PCL
SET:SAPPE
|
TH |
|
Raffles Medical Group Ltd
SGX:BSL
|
SG |
|
E
|
Eles Semiconductor Equipment SpA
MIL:ELES
|
IT |
|
Tyra Biosciences Inc
NASDAQ:TYRA
|
US |
|
Megaport Ltd
ASX:MP1
|
AU |
|
O
|
Orezone Gold Corp
TSX:ORE
|
CA |
|
J
|
J B Hunt Transport Services Inc
XMUN:JB1
|
US |
|
Taung Gold International Ltd
HKEX:621
|
HK |
|
I
|
Ionic Rare Earths Ltd
OTC:IXRRF
|
AU |
|
Catapult Group International Ltd
ASX:CAT
|
AU |
|
A
|
AirAsia X Bhd
KLSE:AAX
|
MY |
|
S
|
SBM Offshore NV
VSE:SBMO
|
NL |
|
P
|
Publicis Groupe SA
OTC:PGPEF
|
FR |
|
Luceco PLC
LSE:LUCE
|
UK |
Bankruptcy Probability
DBV Technologies SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
DBV Technologies SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
DBV Technologies SA
PAR:DBV
|
890m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
397.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
186.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
160.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
66.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
40.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
DBV Technologies SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, DBV Technologies SA has total debt of 5.4m USD. This includes both short-term (0 USD) and long-term (5.4m USD) debt.
You can find a full breakdown on its Balance Sheet.
